Total Positions
48
Quarter
2025 Q4
Top Holding
KYMR (14.4%)
Top 10 Concentration
62.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 48
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 14.41% | 12.63% |
#1
Prev: #1
|
5.8 | no change | no change |
P
S
|
5,502,710 | $428,165,865 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 9.00% | 7.52% |
#2
Prev: #2
|
3.6 | -618,131 | -15.6% |
P
S
|
3,356,782 | $267,367,686 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 8.76% | 5.74% |
#3
1
Prev: #4
|
3.5 | no change | no change |
P
S
|
19,751,284 | $260,321,923 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 8.15% | 3.64% |
#4
5
Prev: #9
|
5.3 | 275,105 | 8.6% |
P
S
|
3,479,022 | $241,965,980 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 4.46% | 2.10% |
#5
13
Prev: #18
|
1.8 | no change | no change |
P
S
|
5,295,893 | $132,397,325 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 3.98% | 4.44% |
#6
1
Prev: #7
|
1.6 | no change | no change |
P
S
|
1,495,290 | $118,112,957 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GHRS
GH RESEARCH PLC
|
Healthcare | 3.77% | 5.12% |
#7
1
Prev: #6
|
1.5 | no change | no change |
P
S
|
8,827,712 | $112,111,942 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XNCR
XENCOR INC
|
Healthcare | 3.68% | 1.30% |
#8
18
Prev: #26
|
3.8 | 4,393,579 | 160.3% |
P
S
|
7,133,720 | $109,217,253 | 2013 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 3.49% | 2.73% |
#9
5
Prev: #14
|
1.4 | no change | no change |
P
S
|
3,938,641 | $103,704,418 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 3.10% | 2.95% |
#10
2
Prev: #12
|
1.3 | -282,240 | -24.3% |
P
S
|
879,009 | $92,005,872 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 3.01% | 3.09% |
#11
1
Prev: #10
|
1.2 | no change | no change |
P
S
|
8,617,162 | $89,532,313 | 2017 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 2.42% | 1.58% |
#12
11
Prev: #23
|
3.1 | 608,578 | 36.7% |
P
S
|
2,265,674 | $71,912,493 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XOMA
XOMA ROYALTY CO...
|
Healthcare | 2.32% | 4.05% |
#13
5
Prev: #8
|
0.9 | no change | no change |
P
S
|
2,590,303 | $68,876,157 | 2016 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Healthcare | 2.31% | 1.92% |
#14
6
Prev: #20
|
0.9 | -50,000 | -9.0% |
P
S
|
508,031 | $68,510,521 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 2.22% | 2.94% |
#15
2
Prev: #13
|
3.0 | 283,000 | 22.2% |
P
S
|
1,559,595 | $65,939,677 | 2007 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACIU
AC IMMUNE SA
|
Healthcare | 2.10% | 2.32% |
#16
Prev: #16
|
0.8 | no change | no change |
P
S
|
19,822,436 | $62,242,449 | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 2.02% | 1.70% |
#17
4
Prev: #21
|
0.9 | -1,824,246 | -32.2% |
P
S
|
3,835,886 | $60,146,692 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 2.00% | 1.38% |
#18
6
Prev: #24
|
0.8 | no change | no change |
P
S
|
5,750,683 | $59,519,569 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 1.88% | 2.07% |
#19
Prev: #19
|
0.9 | -1,522,129 | -41.7% |
P
S
|
2,127,665 | $55,936,313 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 1.74% | — |
#20
Prev: #—
|
2.7 | 650,000 | no change |
NEW
|
650,000 | $51,616,500 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.69% | 2.32% |
#21
4
Prev: #17
|
0.7 | -85,313 | -5.4% |
P
S
|
1,488,975 | $50,293,922 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IVVD
INVIVYD INC
|
Healthcare | 1.62% | — |
#22
Prev: #—
|
2.6 | 19,525,000 | no change |
NEW
|
19,525,000 | $48,226,750 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SEPN
SEPTERNA INC
|
Healthcare | 1.61% | 3.06% |
#23
12
Prev: #11
|
0.8 | -2,295,008 | -57.1% |
P
S
|
1,720,782 | $47,975,402 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANNX
ANNEXON INC
|
Healthcare | 1.54% | 0.87% |
#24
4
Prev: #28
|
2.7 | 2,128,080 | 30.4% |
P
S
|
9,128,080 | $45,822,962 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 1.40% | 0.67% |
#25
6
Prev: #31
|
2.8 | 3,014,842 | 63.5% |
P
S
|
7,764,842 | $41,697,202 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 0.00% | 6.90% |
Sold All 😨
(Was: #3) |
0.3 | -2,560,916 | -100.0% |
CLOSED
|
— | $— | 2016 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 0.00% | 5.49% |
Sold All 😨
(Was: #5) |
0.3 | -1,414,165 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CELC
CELCUITY INC
|
Healthcare | 0.00% | 1.32% |
Sold All 😨
(Was: #25) |
0.3 | -658,421 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EPIX
ESSA PHARMA INC
|
Unknown | 0.00% | 0.09% |
Sold All 😨
(Was: #42) |
0.3 | -11,668,473 | -100.0% |
CLOSED
|
— | $— | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SABS
SAB BIOTHERAPEU...
|
Healthcare | 0.00% | 0.08% |
Sold All 😨
(Was: #43) |
0.3 | -932,697 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FBRX
FORTE BIOSCIENC...
|
Healthcare | 0.00% | 0.04% |
Sold All 😨
(Was: #44) |
0.3 | -65,350 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NLSP
NLS PHARMACEUTI...
|
Unknown | 0.00% | 0.01% |
Sold All 😨
(Was: #46) |
0.3 | -143,676 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 48 holdings